Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
PCN117 Dalteparin Versus Vitamin K Antagonists for...
Conference

PCN117 Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment: Pharmacoeconomic Analysis of a Prospective Randomized Trial

Authors

Dranitsaris G; Shane L; Woodruff S; Feugere G; Crowther M

Volume

19

Pagination

pp. a154-a155

Publisher

Elsevier

Publication Date

May 2016

DOI

10.1016/j.jval.2016.03.1616

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015